Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2014 Dec;16(12):1079-90.
doi: 10.1007/s12094-014-1238-y. Epub 2014 Nov 1.

Clinical guide SEOM on venous thromboembolism in cancer patients

A J Muñoz Martín  1 , C Font Puig, L M Navarro Martín, P Borrega García, M Martín Jiménez; Spanish Society for Medical Oncology
Affiliations
Practice Guideline

Clinical guide SEOM on venous thromboembolism in cancer patients

A J Muñoz Martín et al. Clin Transl Oncol. 2014 Dec.

Abstract

Venous thromboembolism (VTE) is a common event in cancer patients and one of the major causes of cancer-associated mortality and a leading cause of morbidity. In recent years, the incidence rates of VTE have notably increased; however, VTE is still commonly underestimated by oncologists. VTE is considered an adverse prognostic factor in cancer patients in all settings. In 2011 the Spanish Society of Medical Oncology (SEOM) first published a clinical guideline of prophylaxis and treatment of VTE in cancer patients. In an effort to incorporate evidence obtained since the original publication, SEOM presents an update of the guideline for thrombosis and cancer in order to improve the prevention and management of VTE.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Management of recurrent cancer-associated thrombosis (CAT)
See this image and copyright information in PMC

References

    1. Epstein AS, Soff GA, Capanu M, Crosbie C, Shah MA, Kelsen DP, et al. Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer. Cancer. 2012;118:3053–3061. doi: 10.1002/cncr.26600. - DOI - PubMed
    1. Sørensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343:1846–1850. doi: 10.1056/NEJM200012213432504. - DOI - PubMed
    1. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–926. doi: 10.1136/bmj.39489.470347.AD. - DOI - PMC - PubMed
    1. Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al. Rating quality of evidence of and strength of recommandations. BMJ. 2008;336:1049–1051. doi: 10.1136/bmj.39493.646875.AE. - DOI - PMC - PubMed
    1. Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH, Tomkowski W, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomized placebo controlled trial. BMJ. 2006;332:325–329. doi: 10.1136/bmj.38733.466748.7C. - DOI - PMC - PubMed

Publication types

MeSH terms